We are live on
!
Find out more
Group One Trading Portfolio holdings
AUM
$52.2B
1-Year Est. Return
104.56%
This Fund
S&P 500
This Quarter
Est. Return
-6.56%
1 Year Est. Return
+104.56%
3 Year Est. Return
+314.05%
5 Year Est. Return
+338.55%
10 Year Est. Return
+1,999.92%
AUM
$92.6B
AUM Growth
+$9.69B
(+12%)
Cap. Flow
+$13.5B
Cap. Flow
% of AUM
14.59%
Top 10 Holdings %
Top 10 Hldgs %
32.73%
Holding
9,211
New
1,117
Increased
3,336
Reduced
3,411
Closed
1,099
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Carvana
CVNA
|
+$89.9M |
| 2 |
Hilton Worldwide
HLT
|
+$36.3M |
| 3 |
General Motors
GM
|
+$33.1M |
| 4 |
Illumina
ILMN
|
+$32M |
| 5 |
Live Nation Entertainment
LYV
|
+$26.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$61.7M |
| 2 |
Salesforce
CRM
|
+$53.2M |
| 3 |
GE Aerospace
GE
|
+$51.2M |
| 4 |
Amazon
AMZN
|
+$47.7M |
| 5 |
Teladoc Health
TDOC
|
+$43.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 0.94% |
| 2 | Technology | 0.92% |
| 3 | Healthcare | 0.79% |
| 4 | Financials | 0.4% |
| 5 | Industrials | 0.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4901
Thomson Reuters
TRI
$46B
| $262K | ﹤0.01% |
2,246
-992
| -31% | -$116K |
|
|
TCRR
4902
CALL
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $262K | ﹤0.01% |
30,800
+29,200
| +1,825% | +$413K |
|
4903
PUT
FreightCar America
RAIL
$243M
| $261K | ﹤0.01% |
57,700
+14,000
| +32% | +$73.8K |
|
|
MSB
4904
Mesabi Trust
MSB
$305M
| $260K | ﹤0.01% |
8,747
-5,000
| -36% | -$167K |
|
4905
PUT
MGIC Investment
MTG
$6.33B
| $260K | ﹤0.01% |
17,400
-41,800
| -71% | -$606K |
|
|
EGIO
4906
PUT
DELISTED
Edgio, Inc. Common Stock
EGIO
| $260K | ﹤0.01% |
2,728
-2,330
| -46% | -$246K |
|
|
SUNW
4907
PUT
DELISTED
Sunworks, Inc.
SUNW
| $260K | ﹤0.01% |
42,400
-29,900
| -41% | -$235K |
|
4908
PUT
Ardmore Shipping
ASC
$707M
| $259K | ﹤0.01% |
62,500
-7,400
| -11% | -$26.2K |
|
|
ZYNE
4909
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
| $259K | ﹤0.01% |
61,200
-34,600
| -36% | -$154K |
|
4910
CALL
Forte Biosciences
FBRX
$1.57B
| $258K | ﹤0.01% |
+3,492
| New | +$1.93M |
|
4911
PUT
Nexstar Media Group
NXST
$5.81B
| $258K | ﹤0.01% |
1,700
-7,400
| -81% | -$1.09M |
|
4912
PUT
Geron
GERN
$982M
| $257K | ﹤0.01% |
187,400
-107,900
| -37% | -$144K |
|
4913
CALL
Minerva Neurosciences
NERV
$187M
| $257K | ﹤0.01% |
18,475
+9,112
| +97% | +$137K |
|
4914
PUT
Pluri
PLUR
$17.9M
| $257K | ﹤0.01% |
12,113
-5,762
| -32% | -$148K |
|
4915
PUT
Cricut
CRCT
$1.24B
| $256K | ﹤0.01% |
+9,300
| New | +$303K |
|
4916
CALL
BioXcel Therapeutics
BTAI
$34.9M
| $255K | ﹤0.01% |
525
-144
| -22% | -$63.3K |
|
4917
Lloyds Banking Group
LYG
$90B
| $255K | ﹤0.01% |
+104,132
| New | +$255K |
|
4918
Magnolia Oil & Gas
MGY
$6.13B
| $255K | ﹤0.01% |
14,358
+12,133
| +545% | +$183K |
|
4919
Pool Corp
POOL
$7.29B
| $255K | ﹤0.01% |
587
-3,000
| -84% | -$1.42M |
|
|
STEX
4920
PUT
Streamex Corp
STEX
$90.3M
| $254K | ﹤0.01% |
8,510
+1,550
| +22% | +$50.4K |
|
|
CPRX
4921
PUT
DELISTED
Catalyst Pharmaceutical
CPRX
| $254K | ﹤0.01% |
47,900
-9,900
| -17% | -$54.1K |
|
4922
Hain Celestial
HAIN
$53.9M
| $254K | ﹤0.01% |
+5,927
| New | +$235K |
|
|
LVOX
4923
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
| $253K | ﹤0.01% |
38,727
-35,474
| -48% | -$256K |
|
|
SRTA
4924
PUT
Strata Critical Medical Inc
SRTA
$528M
| $252K | ﹤0.01% |
24,200
+13,800
| +133% | +$121K |
|
4925
Healthpeak Properties
DOC
$14.3B
| $252K | ﹤0.01% |
7,531
+3,497
| +87% | +$124K |
|
Similar funds
SCP
RIM
Group One Trading's Q3 2021 Portfolio in Review
As of Q3 2021, Group One Trading held 9,211 positions worth $92.6B, up 12% from $82.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Group One Trading deployed $13.5B of net new capital in Q3 2021, opening 1,117 new positions and adding to 3,336 existing holdings. Its largest new stake was Carvana: 1,351,895 shares worth $81.5M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 0.94% of assets, down from 1% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Gilead Sciences, an estimated $61.7M trimmed.
- Group One Trading's largest Q3 2021 buy was Carvana: 1,351,895 shares worth $81.5M.
- Group One Trading added most to Hilton Worldwide in Q3 2021, an estimated $36.3M increase.
- Group One Trading's biggest Q3 2021 reduction was Gilead Sciences, cutting an estimated $61.7M.
- Group One Trading fully exited Salesforce in Q3 2021, selling an estimated $53.2M.
- Group One Trading's ten largest holdings make up 33% of its $92.6B portfolio in Q3 2021.
- Group One Trading opened 1,117 new positions and closed 1,099 in Q3 2021.
- Group One Trading's portfolio value rose 12% quarter-over-quarter to $92.6B.
Based on Group One Trading's 13F filing for Q3 2021, filed 12 Nov 2021.